• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.

作者信息

Look A T, Dahl G V, Rivera G, Mauer A M

出版信息

Cancer Chemother Pharmacol. 1982;7(2-3):161-7. doi: 10.1007/BF00254540.

DOI:10.1007/BF00254540
PMID:6177437
Abstract
摘要

相似文献

1
Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.难治性急性非淋巴细胞白血病治疗期间鬼臼乙叉甙（VP16 - 213）疗效的临床及细胞动力学研究
Cancer Chemother Pharmacol. 1982;7(2-3):161-7. doi: 10.1007/BF00254540.
2
Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):995-9.
3
Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.依托泊苷单药及联合化疗用于儿童急性白血病
Cancer Treat Rev. 1982 Jun;9 Suppl:53-7. doi: 10.1016/s0305-7372(82)80078-9.
4
Cyclophosphamide/etoposide: effective reinduction therapy for children with acute nonlymphocytic leukemia in relapse.环磷酰胺/依托泊苷：复发性急性非淋巴细胞白血病患儿有效的再诱导治疗方法
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):887-9.
5
Etoposide in the treatment of acute leukemia in adults.依托泊苷治疗成人急性白血病
Cancer Treat Rev. 1982 Jun;9 Suppl:59-62. doi: 10.1016/s0305-7372(82)80079-0.
6
[A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].依托泊苷（VP - 16）静脉给药治疗恶性淋巴瘤和急性白血病的II期试验
Rinsho Ketsueki. 1985 Nov;26(11):1774-84.
7
Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).安吖啶单独或与5-氮杂胞苷及依托泊苷联合用于难治性或复发性急性非淋巴细胞白血病（ANLL）。
Haematologica. 1985 Jan-Feb;70(1):39-43.
8
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].依托泊苷（VP 16/NK 171）与阿糖胞苷联合化疗用于儿童难治性白血病
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):951-8.
9
Azacitidine: 10 years later.阿扎胞苷：十年之后。
Cancer Treat Rep. 1987 Jul-Aug;71(7-8):737-46.
10
Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors.依托泊苷（VP16）在难治性实体瘤儿童及青少年中的药代动力学
Cancer Res. 1984 Jul;44(7):3109-13.

引用本文的文献

1
Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma.VP16 - 213治疗Lewis肺癌后DNA分布的流式细胞术分析
Cancer Chemother Pharmacol. 1983;10(3):208-11. doi: 10.1007/BF00255765.
2
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.替尼泊苷耐药L1210细胞中的耐药及交叉耐药表达
Cancer Chemother Pharmacol. 1987;19(2):123-30. doi: 10.1007/BF00254563.
3
The clinical pharmacology of etoposide and teniposide.依托泊苷和替尼泊苷的临床药理学

本文引用的文献

1
A simplified method of DNA distribution analysis.一种简化的DNA分布分析方法。
Cell Tissue Kinet. 1980 May;13(3):299-308. doi: 10.1111/j.1365-2184.1980.tb00468.x.
2
Treatment of acute myelogenous leukemia in children and adults.儿童和成人急性髓性白血病的治疗。
N Engl J Med. 1980 Aug 28;303(9):473-8. doi: 10.1056/NEJM198008283030901.
3
Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):995-9.
Clin Pharmacokinet. 1987 Apr;12(4):223-52. doi: 10.2165/00003088-198712040-00001.
4
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。
Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.
4
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Cancer. 1974 Oct;34(4):985-92. doi: 10.1002/1097-0142(197410)34:4<985::aid-cncr2820340402>3.0.co;2-u.
5
5-Azacytidine: a new active agent for the treatment of acute leukemia.
Blood. 1973 Sep;42(3):359-65.
6
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.4'-去甲基表鬼臼毒素9-(4,6-O-2-亚噻吩基-β-D-吡喃葡萄糖苷)(NSC-122819；VM-26)和4'-去甲基表鬼臼毒素9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(NSC-141540；VP-16-213)用于儿童癌症的初步观察
Cancer Chemother Rep. 1975 Jul-Aug;59(4):743-9.
7
Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.关于鬼臼毒素及表鬼臼毒素（VM - 26、VP - 16 - 213）对人淋巴母细胞细胞周期进程作用的细胞荧光分析研究。
J Cell Biol. 1975 Sep;66(3):521-30. doi: 10.1083/jcb.66.3.521.
8
Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213.体外暴露于VP-16-213的人淋巴瘤细胞的存活及细胞周期进程延迟
Cancer Treat Rep. 1976 Sep;60(9):1295-1306.
9
Multi-user system for analysis of data from flow cytometry.
Comput Programs Biomed. 1979 Dec;10(3):218-30. doi: 10.1016/0010-468x(79)90071-0.
10
Advances in the treatment of acute myelogenous leukemia.急性髓性白血病的治疗进展
N Engl J Med. 1979 May 24;300(21):1189-99. doi: 10.1056/NEJM197905243002105.